Dare Bioscience, Inc.DARE

Market cap

$331.17M

P/E ratio

	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Total revenue	0	-	1	-	-	-	-	-	10
General and administrative	9	11	10	3	5	5	7	8	11
Research and development	12	26	28	984,749	6	9	21	31	30
License fee expense	-	-	-	-	-	-	-	-	100,000
Total operating expenses	20	37	38	11	17	14,344,880	27	39	41
Loss from operations	-	-	-	-11,180,488	-16,882,312	-14,344,880	-27	-39,068,512	-31,385,488
Other income	-3	-	-	-	143,497	81,050	1,514	2,520	437,750
Gain (Loss) on Extinguishment of Debt	-2	-	-	-	-	-	-	369,887	-
Net loss	-23	-40	-39	-11,503,117	-16,738,815	-14,263,830	-27,400,743	-39	-31
Net loss to common shareholders	-23	-	-	-	-	-15,053,424	-27,407,606	-38,696,105	-30,947,738
Foreign currency translation adjustments	-	-	-	-18,080	-78,648	-5,897	11,237	-63,585	-196,338
Comprehensive loss	-	-	-	-11,521,197	-16,817,463	-15,059,321	-27,396,369	-38,759,690	-31,144,076
Earnings Per Share, Basic	-	-	-	-	-	-	-	-0.63	-0.37
Earnings Per Share, Diluted	-	-	-	-	-	-	-	-0.63	-0.37